Virtu Financial LLC Acquires New Position in Solventum Co. (NYSE:SOLV)

Virtu Financial LLC purchased a new position in shares of Solventum Co. (NYSE:SOLV - Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 8,141 shares of the company's stock, valued at approximately $568,000.

Several other hedge funds have also modified their holdings of SOLV. Deseret Mutual Benefit Administrators acquired a new position in shares of Solventum in the 2nd quarter worth approximately $25,000. Hollencrest Capital Management acquired a new position in Solventum during the second quarter worth approximately $25,000. Richard W. Paul & Associates LLC acquired a new position in shares of Solventum in the second quarter valued at approximately $26,000. Family Firm Inc. acquired a new stake in Solventum during the second quarter worth approximately $26,000. Finally, Copeland Capital Management LLC acquired a new stake in shares of Solventum in the 3rd quarter valued at $26,000.

Analysts Set New Price Targets

SOLV has been the subject of several analyst reports. Mizuho assumed coverage on Solventum in a research report on Wednesday, December 4th. They set a "neutral" rating and a $70.00 target price for the company. BTIG Research started coverage on shares of Solventum in a research report on Thursday, September 5th. They set a "neutral" rating on the stock. Morgan Stanley lifted their price target on shares of Solventum from $60.00 to $73.00 and gave the stock an "equal weight" rating in a report on Monday, November 11th. Wolfe Research began coverage on shares of Solventum in a report on Thursday, September 26th. They set a "peer perform" rating on the stock. Finally, Stifel Nicolaus started coverage on shares of Solventum in a research report on Tuesday, October 8th. They set a "buy" rating and a $82.00 price target for the company. One equities research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has assigned a buy rating to the company's stock. Based on data from MarketBeat, Solventum currently has an average rating of "Hold" and an average target price of $68.29.

Solventum Stock Down 0.6 %

SOLV traded down $0.45 on Friday, reaching $69.56. 637,853 shares of the company traded hands, compared to its average volume of 824,329. Solventum Co. has a one year low of $47.16 and a one year high of $96.05. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The firm has a fifty day simple moving average of $70.91 and a two-hundred day simple moving average of $63.22.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.